[HTML][HTML] Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections

Y Liu, R Qin, SAJ Zaat, E Breukink… - Journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Antibacterial photodynamic therapy (APDT) has drawn increasing attention from the
scientific society for its potential to effectively kill multidrug-resistant pathogenic bacteria and …

Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment

A Borhani-Haghighi, B Kardeh, S Banerjee… - Multiple sclerosis and …, 2020 - Elsevier
Neuro-Behcet's disease (NBD) is defined as a combination of neurologic symptoms and/or
signs in a patient with Behcet's disease (BD). Relevant syndromes include brainstem …

Review of advances in uroprotective agents for cyclophosphamide-and ifosfamide-induced hemorrhagic cystitis

EL Matz, MH Hsieh - Urology, 2017 - Elsevier
Cyclophosphamide and ifosfamide are widely used drugs for malignancies and
rheumatologic conditions. One of the most significant adverse reactions to these drugs is …

Prevention of complications from use of conventional immunosuppressants: a critical review

C Ponticelli, RJ Glassock - Journal of nephrology, 2019 - Springer
Synthetic immunosuppressive drugs are largely used in immune-related renal diseases and
in kidney transplantation. Most of these drugs have a low therapeutic index (the ratio that …

Chemical Profiling of Polyphenolics in Eucalyptus globulus and Evaluation of Its Hepato–Renal Protective Potential Against Cyclophosphamide Induced Toxicity in …

MA Ghareeb, M Sobeh, WH El-Maadawy… - Antioxidants, 2019 - mdpi.com
Cyclophosphamide (CP) is a potent anti-neoplastic and immunosuppressive agent;
however, it causes multi-organ toxicity. We elucidated the protective activities of Eucalyptus …

Does cyclophosphamide still play a role in glomerular diseases?

C Ponticelli, R Escoli, G Moroni - Autoimmunity Reviews, 2018 - Elsevier
Cyclophosphamide is a prodrug that is converted to inactive carboxy-cyclophosphamide,
acrolein and phosphoramide mustard, an agent that adds alkyl groups to oxygen and …

Complications of immunosuppression in glomerular disease

JA Jefferson - Clinical Journal of the American Society of …, 2018 - journals.lww.com
Most glomerular diseases are immunologically mediated disorders of the kidney and are
common causes of ESKD. In addition to supportive therapy, a wide range of …

[HTML][HTML] Combination of rituximab, low-dose cyclophosphamide, and prednisone for primary membranous nephropathy: a case series with extended follow up

R Zonozi, K Laliberte, NR Huizenga… - American Journal of …, 2021 - Elsevier
Rationale & Objective B-cell depletion with rituximab has emerged as a first-line therapy for
primary membranous nephropathy (MN). However, most patients do not achieve complete …

The nephrotoxicity of drugs used in causal oncological therapies

J Hałka, S Spaleniak, G Kade, S Antosiewicz… - Current …, 2022 - mdpi.com
In recent years, a dynamic development of oncology has been observed, resulting from the
increasingly frequent occurrence of neoplasms and therefore, increasing population of …

Downregulation of redox imbalance and iNOS/NF-ĸB/caspase-3 signalling with zinc supplementation prevents urotoxicity of cyclophosphamide-induced hemorrhagic …

AC Famurewa, CO Edeogu, FI Offor, EE Besong… - Life Sciences, 2021 - Elsevier
Aim Cyclophosphamide (CYP) chemotherapy induces bladder toxicity and hemorrhagic
cystitis in cancer patients constituting a current clinical concern. Oxidative inflammatory …